Form 4 for BJDX Bluejay Diagnostics, Inc.
Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-27 · accession 0001213900-23-023546 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-28 | 2023-03-27+ | BJDX | Dey Indranil | Pres, CEO, Dir | A - Grant | $0.44 | +10.0K | 660.5K | +2% | +$4,400 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-27 | A | A | 8,000 | $0.44 | 558,538 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-28 | A | A | 2,000 | $0.44 | 660,538 | D | — | — |